接受者全周Descemet膜剥除用于虹膜角膜内皮综合征的内皮角膜移植术的临床结局
一项随机对照临床试验纳入48例(48眼)虹膜角膜内皮综合征患者,比较接受者全周Descemet膜剥除与标准技术行Descemet膜内皮角膜移植术(DMEK)的结局。术后2年,全周剥除组内皮细胞丢失率为66%±5%,标准组为74%±4%(95%CI:-0.04至0.01;P=.040),两组累积移植成功率分别为83%和67%(95%CI:-0.07至0.39;P=.318),术后矫正远视力及主要并发症发生率两组无显著差异。作者认为全周剥除可能延缓ICE综合征的病理进展,从而减少DMEK术后内皮细胞丢失。
要点
- 术后2年内皮细胞丢失率全周剥除组66%±5% vs 标准组74%±4%(95%CI:-0.04至0.01;P=.040)。
- 累积移植成功率全周剥除组83% vs 标准组67%(95%CI:-0.07至0.39;P=.318)。
- 术后矫正远视力及主要并发症发生率两组无显著差异。
核心结论
- 接受者全周Descemet膜剥除可能延缓ICE综合征的病理进展,从而减少DMEK术后内皮细胞丢失。
研究设计与样本
- 随机对照临床试验,纳入2014年3月10日至2022年5月11日期间48例(48眼)虹膜角膜内皮综合征患者,分为全周剥除组(24眼)和标准技术组(24眼),所有病例均行DMEK并联合其他手术。
主要发现
- 术后9个月随访时,全周剥除组内皮细胞丢失显著低于标准组。
- 术后2年,内皮细胞丢失率全周剥除组66%±5% vs 标准组74%±4%(95%CI:-0.04至0.01;P=.040)。
- 术后2年,累积移植成功率全周剥除组83% vs 标准组67%(95%CI:-0.07至0.39;P=.318)。
- 整个随访期间两组术后矫正远视力水平相当。
- 两组主要并发症发生率无显著差异。
关键数值与推荐
- 术中剥除接受者全周Descemet膜或中央直径8.0或8.25 mm的Descemet膜。
- 主要结局指标为内皮细胞丢失、矫正远视力、眼压、移植存活率和手术并发症,于术后9、12和24个月进行比较。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate whether a recipient's entire Descemet stripping reduced endothelial cell loss (ECL) after Descemet membrane endothelial keratoplasty (DMEK) for iridocorneal endothelial (ICE) syndrome. DESIGN: Randomized controlled clinical trial. METHODS: A total of 48 patients (48 eyes) with ICE syndrome were enrolled between 10 March 2014 and 11 May 11 2022. The eligible patients were divided into the entire recipient's Descemet stripping group (entire stripping group, 24 eyes) or the standard technique group (standard group, 24 eyes). DMEK was performed in all cases with concomitant procedures. The recipient's entire Descemet membrane or the central 8.0- or 8.25-mm diameter of the Descemet membrane was removed intraoperatively. Main outcome measures were ECL, corrected distance visual acuity (CDVA), intraocular pressure (IOP), graft survival, and surgical complications, which were compared 9, 12, and 24 months after surgery. RESULTS: After a 9-month follow-up, ECL was significantly lower in the entire stripping group than in the standard group. At 2 years postoperatively, the ECL rate was 66% ± 5% and 74% ± 4% (95% CI: -0.04 to 0.01; P = .040), with a cumulative graft success rate of 83% and 67% (95% CI: -0.07 to 0.39; P = .318) in the entire stripping group and the standard group, respectively. The postoperative CDVA level was comparable between the 2 groups throughout the follow-up period. No significant differences between the 2 groups were observed in regard to the incidence of main complications. CONCLUSIONS: Entire recipient's Descemet stripping may delay the pathological progression of ICE syndrome, thereby reducing ECL after DMEK.
引用
- Dong X, Ouyang C, Ye Q, et al. Clinical Outcomes of Endothelial Keratoplasty With a Recipient's Entire Descemet Stripping for Iridocorneal Endothelial Syndrome. Am J Ophthalmol. 2024. PMID: 39343337. doi:10.1016/j.ajo.2024.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。